Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiers.
- DOI
- 10.1016/j.tranon.2026.102851
- Published
- 2026-06-06
- Container
- Transl Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2026.102851,
title = {Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiers.},
author = {Garg P and Horne D and Salgia R and Singhal SS.},
year = {2026},
journal = {Transl Oncol},
doi = {10.1016/j.tranon.2026.102851},
url = {https://doi.org/10.1016/j.tranon.2026.102851}
}RIS
TY - JOUR TI - Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiers. AU - Garg P AU - Horne D AU - Salgia R AU - Singhal SS. PY - 2026 JO - Transl Oncol DO - 10.1016/j.tranon.2026.102851 UR - https://doi.org/10.1016/j.tranon.2026.102851 ER -
APA
P, G., D, H., R, S., & SS., S. (2026). Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiers.. Transl Oncol. https://doi.org/10.1016/j.tranon.2026.102851
Source records
- europe-pmc · retrieved 2026-09-26T20:35:33.633Z